Antibody affinity is critically important in therapeutic applications, as well as steady state diagnostic assays. Picomolar-affinity antibodies, approaching the association limit of protein-protein interactions, have been discovered for highly potent antigens, but even such high-affinity binders have offrates sufficient to negate therapeutic efficacy. To cross this affinity threshold, antibodies which tether their targets in a manner other than reversible non-covalent interaction will be required. Here we report the design and construction of an antibody which forms an irreversible complex with a protein antigen in a metal dependent reaction. The complex resists thermal and chemical denaturation, as well as attempts to remove the coordinating metal ion. Such irreversibly-binding antibodies could facilitate the development of next-generation "reactive antibody" therapeutics and diagnostics.
Antibodies are the most prominent superfamily of binding proteins, demonstrating exquisite affinity and specificity towards all classes of molecules. This is accomplished by optimization of steric, electrostatic, and hydrogen bonding interactions of the antibody with target functional groups, giving rise to a well-formed interface. Such reversible noncovalent driving forces may produce spectacularly high affinities, with picomolaraffinity antibodies raised against botulinum neurotoxin (1), ErbB2 (2), gp120 (3) , and TNFα (4) being among the tightest proteinprotein interactions known. The remarkably tight-binding antibodies to botulinum neurotoxin, however, were by themselves shown to be insufficient to protect from the toxicity of such potent catalytic toxins (5) , single molecules of which have been shown to cause cell death (6) . In addition to neutralizing potent toxins, antibodies with superior binding performance serve as "sinks" to remove tissue antigens into serum.
Examples of such clinically relevant targets include VEGF (7), β-amyloid (8) , or even TNF (9) .
An alternative method to increase target inactivation is the use of reactive antibodies, which perform chemistry to irreversibly modify their target antigen. Such chemistry may result in turnover (catalytic antibodies (10)), target modification and release but no turnover ("suicide" antibodies (11)), or an irreversible complex with antigen (covalent antibodies (12) ). Catalytic antibodies which act on small molecule substrates have been known for some time, and a variety of catalyzed reactions have been discovered (10) . More recently, catalytic antibodies whose substrates are proteins have been found, apparently proteolytically cleaving a target amide bond via a serine protease-like triad (13, 14) . Indeed, it has recently become apparent that such catalytic antibodies may be produced endogenously, with potential clinical impact (15) (16) (17) . Irreversibly-binding antibodies have been raised against electrophilicallymodified targets (18) and have been shown to form an effectively covalent complex with their antigen. In another experiment, a covalent antibody was developed by engineering both the antibody and antigen. A metal chelatebinding antibody was rendered covalent via introduction of specific nucleophilic cysteine residues into the antibody, and electrophilic substituents onto the metal chelate antigen (12) .
In the broadest scope, the potential reactive kinetics of antibodies can be represented by:
Where k 1 and k -1 indicate the binding on and off rates typical of a standard antibody, k react indicates a covalent modification of the target antigen (Ag), producing a modified antigen (Ag*), and k 3 and k -3 indicate the binding on and off rates of the antibody for the modified antigen. If the antibody binds covalently to the antigen, the off-rate (k -1 ) would be effectively zero. Alternatively, if the antibody dissociates from Ag* (and is not modified itself), then catalytic turnover would have occurred. Thus, the complete sequence illustrates the catalytic cycle of an Abzyme.
Metal ions are highly reactive species that function in biology, and provide a unique opportunity for the engineering of chemical reactivity into biomolecules (19) . In addition, their comparatively small size and simple coordination geometry make metal-binding sites relatively facile to engineer (20) . Antibodies or antibody fragments which specifically recognize metals have been raised against Cu(II), Zn(II), Pb(II), Ce(III), Fe (II), Pb(II), Cd(II) (21, 22) , Hg(II) (23) , indium (24) , and lanthanides (25) , either by traditional hybridoma methods (22, 23, 25) or by phage display (21) . Additionally, non-metal binding antibodies have been rationally engineered to bind Zn(II) (26) . Furthermore, antibodies have been discovered which perform metaldependent catalysis on small molecule or peptide substrates. Antibodies raised against a transition state analog can catalytically insert Zn(II), Co(II), Cu(II), or Mn(II) into porphyrins (27) ; and antibodies raised against a peptidemetal chelate can proteolytically cleave dipeptide substrates (28) . We report the first antibody fragment to perform metal-driven chemistry on a larger protein target.
Here we describe the engineering of a metalbased reactive motif into an antibodycombining site.
This methodology could provide a general strategy for the development of antibodies which form effectively-covalent complexes with unmodified target protein antigens.
These and other such reactive antibodies could extend the repertoire of functions performed by immunoglobulin scaffolds beyond reversible binding, allowing for the creation of novel therapeutics and diagnostics.
EXPERIMENTAL PROCEDURES
Library construction. PCR was performed on a pCANTAB5E based plasmid lacking a 6xHis tag (Amersham) encoding RA7, a human anti-TNF scFv, using a 5' V H gene primer (TGTTCCTTTCTATGCGGCCCAGCCGGCC ATGGCCNNKNNKCATGAGNNKNNKCACN NKNNKGAGGTGCAGCTGGTGGAGTCCG G) containing a degenerate xxHExxHxx motif (italics; the codon NNK encodes all 20 amino acids and a stop codon) and an SfiI restriction site (underlined), and a 3' reverse primer (CGAGCCACCGCCACCTGCGGCCGCTGA GGAGACAGTGACCAGGG) containing a NotI restriction site (underlined). The vector is in the format V H -linker-V L -E-tag-gIII, where Etag is a peptide tag for detection with anti-E-tag antibodies. After 30 cycles of polymerase chain reaction with a high fidelity DNA polymerase (Pfu; Stratagene), the heavy chain PCR products were purified (Qiagen PCR purification kit), digested with SfiI and NotI, gel isolated, ligated into dephosphorylated RA7 vector, and transformed into E.coli TG1 by electroporation, yielding a library of 1x10 independent clones. Phage were produced from the transformation by the addition of 1x10 9 /ml M13K07 helper phage and ampicillin. After growth for 1.5 hours at 37°C, the infected cells were centrifuged, the media replaced with 10 ml of 2xYT containing ampicillin and kanamycin, and growth resumed at 30°C with shaking overnight. Phage were precipitated by the addition of PEG 8000 to 4% and NaCl to 0.5M, incubated on ice for 1 hour, centrifuged at 10,000 g for 30 minutes, and resuspended in TBST (TRIS-buffered saline; 20 mM Tris pH 7.4, 150 mM NaCl, 0.1% Tween).
Library screening. HExxH antibody genes were expressed on the surface of phage as scFv-g3p fusion proteins. Selection for phage which bound metal was accomplished by incubating 1x10 9 phage with 0.25 ml of a pentadentate metal chelate resin (Affiland; loaded with either nickel or copper) that was pre-blocked with 1% BSA in TBST. Albumin was chosen both for its blocking of nonspecific protein binding, as well as its lowaffinity endogenous metal-binding capacity (45) . Adsorption was for 1 hour at 25°C, followed by extensive washing with TBST, and serial elution of phage with 1 column volume of increasing concentrations of imidazole in TBS. Imidazole elution fractions of phage were mixed with an equal volume of loggrowth TG1 cells (OD 600 = 0.5) for 20 minutes at room temperature. Infections were done immediately after elution, as imidazole was found to decrease phage infectivity after prolonged incubation. One to ten μl of the infection was plated to determine the percent recovery of metal binding phage from the library.
ELISA.
Individual phage clones (0.4 ml cultures in a 96-well block) were screened for metal binding by ELISA using specifically designed 96-well plates that chelate copper (Pierce) according to the manufacturer's instructions. Briefly, phage supernatant (5 μl) in 50 μl TBS (TRIS-buffered saline pH 7.4) was applied to each well and incubated for 1 hour at 25°C. The wells were then washed three times in TBST, blocked with chelate blocker (Pierce), and incubated with an anti-M13-HRP (horseradish peroxidase) labeled antibody (1:5000 dilution; Amersham) for one hour, and developed with QuantaBlu fluorescent HRP substrate according to the manufacturer's instructions (Pierce). Fluorescence was detected at 334 nm excitation/420 nm emission in a Fluoromax plate reader (Molecular Devices). Phage clones that bound metal were identified by comparison to a control phage which binds metal via a 6xHis metal-affinity tag. Negative controls included M13K07 helper phage and RA7 (without a 6xHis tag).
Clones which bound metal were characterized further in an ELISA assay of TNF binding. ELISA plates were coated with recombinant TNFα (Biosource) at 0.5 μg/ml in PBS (overnight, 4°C), blocked with 2% non-fat milk in PBS, 5-10 μl of phage in 50 μl PBS was added and incubated for 1 hour at 37°C, washed with TBST, incubated with anti-M13-HRP antibody (Amersham), and developed with QuantaBlu (Pierce).
Protein Purification. Phagemid clones which were found to bind both metal and TNF were transferred into E.coli Top10F' (Invitrogen), a non-suppressor strain used to produce soluble scFv antibodies (instead of phage scFv-g3p fusions as in TG1 cells). A 5 ml overnight culture was used to start a 50 ml culture in terrific broth (Fischer), grown at 30°C for several hours (OD 600 ~ 0.6), induced with 0.2 mM IPTG and grown overnight at 30°C. Cells were centrifuged, and soluble antibody was prepared from culture supernatant. For larger scale preparations, 1 L cultures were harvested by centrifugation for 30 minutes at 3500 g, and the pellet resuspended in 20 ml of 20 mM Tris pH 7.4, 1 mM EDTA, 20% sucrose, 5 μg/ml lysozyme and incubated at 4°C with gentle agitation for 2 hours. The samples were centrifuged for 30 minutes at 10,000 g, and the supernatants were saved as the periplasmic extract. The extracts were dialyzed (10,000 kDa cutoff) against 20 mM Tris / 50 mM NaCl, pH 7.0 for further purification. Dialysis buffers were changed 3 times over the course of 2 days. Culture supernatants or periplasmic extracts were mixed with an equal volume of 2 M Na 2 SO 4 in 2xPBS and applied to thiophilic resin (Clontech).
Protein was eluted by decreasing the concentration of Na 2 SO 4 in 100 mM step fractions in one column volume to a final elution in PBS alone. Protein was buffer exchanged into 50 mM MES / 50 mM NaCl, pH 6.1 using Amicon microconcentrators (10,000 MWCO) and applied to 0.5 ml of packed CM-sepharose, washed with five column volumes of the same buffer, and eluted with 50 mM step gradients of NaCl. The antibody scFv eluted between 150 and 250 mM NaCl which was detected by slot blot evaluation of step gradient elutions using an anti-E-tag-HRP conjugated antibody (1:4000 dilution, Amersham).
Prior to antigen incubation, protein was again buffer exchanged into TBS pH 7.4, using Amicon microconcentrators. Size exclusion HPLC was performed in TRIS buffered saline on a BioSep SEC-S 3000 preparatory column (Phenomenex). Final scFv yields were 0.3 mg/L for RA72 and 21H9 scFv, and electrophoretically pure as shown in Figure 2b .
Antibody/Antigen Reaction and Western Blot. 100 ng of scFv was incubated with 250 ng human recombinant TNFα (Biosource) in the absence or presence of Co 2+ , or other metals (100 μM unless otherwise indicated, chloride counterion in each case) in TRIS buffered saline pH 7.4 at 37°C for 12 hours, or for the indicated period of time. The ratio of scFv to TNF was approximately 1:1 assuming a TNF trimer at 0.5 μM. In some experiments EDTA was included at 1 mM. When pH was titrated, MES buffer (pKa = 6.15) was used for pH 5-6.5 and TRIS (pKa = 8.3) was used for pH 7-9. Reactions were resolved by SDS-PAGE, transferred to nitrocellulose, blocked with 2% non-fat milk in PBS / 0.05% Tween, incubated with anti-TNFα primary antibody (1:1000 dilution, Santa Cruz Biotechnology) for 45 minutes, then anti-goat secondary antibody conjugated to HRP (Sigma-Aldrich) for 45 minutes, and developed colorimetrically with the metal-enhanced DAB kit (Pierce). When antibody scFv was detected, an anti-E-tag-HRP antibody was used (1:4000 dilution, Amersham). Densitometry (Quanta-One, BioRad) was used to quantify bands. The percent of crosslinking was determined as the amount of crosslinked product at 44 kDa divided by the total activity per lane.
Mass Spectrometry. The scFv/TNF reaction was scaled up 30 fold, resolved on SDS-PAGE, stained with Gel-Code Blue (Pierce), and the 44 kDa band excised. As controls, TNFα and 21H9 were mixed and run side by side at three different dilutions. The bands corresponding to TNFα and 21H9 with the staining intensity nearest the 44 kDa complex in the adjacent lane were also excised. Thus, TNFα alone, and 21H9 alone were processed in an equivalent fashion and at similar concentrations as the 44 kDa complex. The excised gel band was reduced with 10 mM dithiothrietol, alkylated with 55 mM iodoacetamide and digested with trypsin for 18 hours before analysis by nano HPLC-MS-MS on a 15 cm 75 μm ID C 18 column in data-dependent mode using a LTQ linear ion trap mass spectrometer (Thermoelectron Corp.). Peptide identification was performed using Mascot (Matrix Science Limited, UK) and TurboSequest (Thermoelectron Corp.) search engines at 95% confidence level. MALDI-TOF (alpha-cyano-4-hydroxycinammic acid as a matrix) and NIMS-TOF analysis was performed using a VoyagerDE STR time-of-flight (TOF) (Applied Biosytems, Foster City, CA) mass spectrometer in reflectron mode.
Chip preparation and Mass Analysis for NIMS.
A low resistivity (0.01-0.02 Ω-cm) P-type <100> silicon wafer containing Boron as a dopant (Silicon Quest International) was etched with 48 mA/cm illumination from a 300-W tungsten filament. The chips were then soaked in ethyl acetate (0.1% TFA) for 3 minutes and with ozone for ~1 minute. The chips were then treated with neat (heptadecafluoro-1,1,2,2-tetrahydrodecyl)dimethylchlorosilane) (F17) (Gelest, Morrisville, PA) solution at 100 ºC for 30 minutes, rinsed with methanol and dried with a jet of nitrogen. The prepared chips were spotted with the protein digest samples and analyzed using an Applied Biosystems (Framingham, MA) Voyager STR time-offlight (TOF) mass spectrometer in reflectron mode. The chips were attached to a modified MALDI target plate with tape, and the samples were irradiated with a nitrogen laser (337 nm) that was attenuated through a neutral density filter. A delayed extraction of 25-250 ns was used to stabilize the ions produced by laser irradiation. The mass spectra were generated by averaging up to 500 laser pulses.
Molecular Modeling.
Coordinates of the TNFα trimer were taken from the Protein Data Bank file 1TNF (46) . RA7 sequence was aligned with antibodies in the PDB, and the anti-factor IX antibody 10C12 (PDB identifier 1NL0) was found to be the most homologous (87% heavy chain identity; 74% light chain identity). The sequence alignment produced a single 2-residue deletion in the RA7 heavy chain CDR3 sequence relative to 10C12, a single-residue insertion in CDR-L1, and a single-residue deletion in CDR-L3 (all three CDRs are involved in antigen binding in the 1NL0 structure). The 1NL0 backbone topology was preserved, except in the region of these three gaps. In these regions, the Protein Data Bank was searched for antibody structures from which structural elements could be grafted onto this structural template to restore the proper loop size. A sliding window of 1-5 positions before and after the insertion / deletion site was used, and a loop graft was considered viable if it resulted in sufficiently small template-tograft distances (less than 0.25 Å for each corresponding heavy atom pair at each graft terminus) and angle distortions (less than 30 o between the template and graft Cα-Cα vectors at each terminus), and created no intrabackbone steric clashes with the template. The RA7 sequence was then threaded onto this hybrid backbone scaffold, using a high-density backbone-independent rotamer library and a semi-empirical molecular mechanical potential (47) . This preliminary RA7 model was submitted along with 1TNF to the ZDOCK server (48) from which ten proposed interaction poses were collected. The highest-ranking complex model was manually re-docked along with protein side-chain optimization along both halves of the interface. The metal-binding motif was taken from the crystal structure of thermolysin (PDB 4TMN), and was in silico grafted to the N-terminus of the RA7 heavy chain to relieve clashes with both antibody and target, but to keep the motif in proximity to the target. Target moieties (both side-chain and main-chain) in the vicinity of the metal-binding motif were visually identified from the complex model. All molecular modeling was performed with the Chameleon software suite (Looger LL, unpublished results).
RESULTS

Library
Design and Characterization. Irreversible modification of a target protein by an antibody requires placing reactive elements within the combining site without significantly disrupting antigen binding. Such perturbation was successful in the case of a metal chelatebinding antibody by placing nucleophilic cysteine residues in the antibody light chain at positions that were not expected to contact the small molecule antigen based on its co-crystal structure (12) . As a model system, we used an anti-TNFα antibody, RA7 (29) , to engineer reactive metal binding sites. Homology modeling of the RA7 antibody and its complex with the TNFα trimer suggested that the V H Nterminus was within 10 Å of the target. Similarly, a catalytic side-chain has been mapped to the N-terminal residue in a proteolytic light chain (13) . Thus, this Nterminal site was deemed suitable for reactive motif grafting, in close proximity to the antigen but unlikely to substantially affect its approach and binding.
We reasoned that the metalloprotease motif (30) would be sufficient to drive metal binding, and potentially solvent activation. The library diversity would determine the orientation of the motif relative to antibody and target, control motif dynamics, interact with target, and provide side-chains to complete the metal coordination sphere, if necessary. A library was constructed using the consensus metal binding motif HExxH from metalloproteases ( Figure 1A) .
Our library contained xxHExxHxx at the V H N-terminus, where x was any amino acid residue. The phage library (total size ~ 10 7 ) was constructed, and was shown to be unbiased by the sequencing of 20 random clones (data not shown).
We first tested whether the HExxH-containing library retained TNFα binding activity ( Figure  1B ). The monoclonal parent antibody RA7 and its derivative RA72 (differing only in the signal peptide sequence) were used as TNFα-binding controls in an ELISA. The RA72-HExxH library was seen to bind TNFα to nearly the same levels as RA72 ( Figure 1B ). Several monoclonal scFv negative controls (D126, RF26, vFx9) and M13K07 helper phage did not bind TNFα. None of these antibodies bound the negative control antigen BSA. Next we tested whether the HExxH phage could bind a metal affinity column and specifically elute with the histidine side chain competitor imidazole ( Figure 1C ). We used equal titers of the monoclonal non-HExxH parent phage RA72 as a control. Phage were applied to a Ni-NTA resin, washed extensively, and eluted with increasing concentrations of imidazole. One column volume of the final wash step was titered to establish that non-specific phage had been efficiently removed from the column ( Figure 1C , labeled "0"). Few phage eluted from the final wash of either column. The concentration gradient of imidazole was seen to elute 3-4-fold more phage in the HExxH library preparation than in the RA72 control ( Figure  1C ). Twenty clones from the RA72 elutions were sequenced and all were found to be scFv truncation mutants, apparently giving rise to misfolded protein which bound the column. Twenty random clones from the RA72-HExxH elutions were also sequenced, and 20% were truncation mutants. However the remainder contained an intact scFv with the HExxH motif (data not shown).
Thus, full-length scFvphage only eluted from the RA72-HExxH group. Since equal amounts of RA72 and RA72-HExxH phage were loaded onto the two columns, it appears that the eluted phage displaying scFv were due to specific binding of the HExxH motif to the metal column.
Identification of 21H9, a TNF-modifying scFv.
The above experiment was repeated on Cu(II), Co(II), and Zn(II) resins with similar results, except that copper gave higher titers of eluted phage. Since Cu(II) can act as a cofactor in metalloproteases, but can also participate in oxidative chemistry, we chose several clones eluted from the copper column for further analysis. Clones eluting from the other metal resins have not yet been analyzed. Phage clones were tested for copper binding in an ELISA with the RA72 phage and an RA72-6xHis phage used as negative and positive controls, respectively. Two sets of 90 clones were tested by ELISA, and approximately 35 clones that were clearly copper binders were further tested for TNFα binding, to confirm they had not lost antigen binding activity (data not shown). Those scFvs that bound both metal and TNF were purified, to test their reactivity against TNFα. The scFvs were then analyzed for gross TNF modification by western blot. Two clones from this group were seen to produce a new TNF-reactive band at the exact molecular weight of an scFv-TNF fusion protein (17 kDa + 27 kDa = 44 kDa). One clone, 21H9, was characterized further ( Figure  2) . The copper-binding activity of 21H9 is shown in Figure 2A . It was seen to bind copper nearly 4-5-fold greater than the parent RA72 phage (black bars). This reactivity was greatly reduced by the addition of EDTA, strongly suggesting that it is metal specific (Figure 2A , grey bars). We purified the scFv from the 21H9 clone as well as the parent scFv RA72 ( Figure 2B ). The reactivity of each scFv toward TNFα was tested in the absence ( Figure  2C, lanes 1 and 5) or presence (lanes 2-4, 6-9 ) of various metals. A strongly reactive band was seen at 44 kDa only in the 21H9 reaction, and was most prominent in the presence of Co(II) (lanes 6 and 9a). Close inspection showed that it was a very tight doublet. Very weak 44 kDa bands were seen in the presence of Cu(II) (lane 7), Zn(II) (lane 8), or even the absence of exogenous metal (lane 5). We also tested Mg(II), Mn(II), and Fe(II) and found only weak formation of the 44 kDa band (similar to no metal added; data not shown). Since 44 kDa is the molecular weight of a TNF-scFv fusion, and since these reactions were analyzed in the presence of SDS, reducing agent, and following boiling, we reasoned that the 44 kDa band could be a covalent complex that contained both scFv and TNFα. To determine whether the scFv was also present in the 44 kDa band, we re-ran the 21H9 + Co(II) reaction separately and cut the nitrocellulose membrane through the center of the lane ( Figure 2C, lane 9) . The left half was detected with anti-TNFα secondary antibody, and the right half was detected with an anti-scFv antibody. Indeed, both secondary antibodies detected the 44 kDa band (lanes 9a and 9b), strongly suggesting that it is an effectively covalent complex containing both the 21H9 antibody and TNF antigen. A second band at 55 kDa was seen to stain with anti-scFv (lane 9b), and is addressed in further experiments shown in Figure 4 . Thus, the prominent 44 kDa band was dependent on (i) the HExxH motif present in 21H9, (ii) Co 2+ ions, and (iii) the presence of both 21H9 and TNFα.
The sequence of 21H9 was found to encode RGHEARHWA in the library region, with no other sequence changes found in the scFv. In homology searches, a metallo-β-lactamase related protein from Deinococcus radiodurans was found to contain the sequence HEARHW, however, any functional relevance is unclear. The second scFv that was also found to produce the 44 kDa band encoded MRHERAHWW in the library region. Notably, both scFv's with this property encode arginine and alanine in the central positions (though in reverse order) and tryptophan immediately following the second fixed histidine.
We performed several tests on the biochemical parameters dictating formation of the 44 kDa band. First, we examined whether addition of the metal chelator EDTA before or after the 21H9/TNFα/Co 2+ reaction would inhibit complex formation. When EDTA was absent, the 44 kDa complex (labeled "C") was formed as before ( Figure 3A , lane 4). When EDTA was pre-incubated with 21H9 prior to TNF and metal ion addition, no complex was seen to form (lane 5). However, when EDTA was added only at the end of the reaction, it could not disrupt the complex (lane 6). Again, no complex formation was seen for the parent scFv under any of these conditions (lanes 1-3) . These chelator experiments suggest that the metal plays a direct role in the mechanism of complex formation. Further, if metal is present in the 44 kDa complex as a "bridge" between antigen and antibody, it cannot be easily removed once the complex is formed. Such an exchange inert complex could be plausible in the presence of Co (III) (31) . Thus, the final complex either (i) does not contain metal, or (ii) the metal is inert to exchange with other coordinating ligands.
We formally tested the ability of the 44 kDa complex to resist harsh denaturants ( Figure  3B ).
When 4M guanidinium-HCl was incubated with the complex, it was not disrupted on SDS-PAGE (lane 3). When the complex was heated to 95°C, it was actually seen to increase in intensity (lane 4). However, when the complex was simultaneously subjected to guanidinium and heat, it was seen at untreated levels (lane 5). Thus, denaturation with guanidinium appears to abrogate the paradoxic positive effect of heat on complex formation. Neither heat, guanidinium, or 500 mM NaCl (lane 6) however, were able to disrupt the complex once it was formed. Additionally, incubation with 10 mM ZnCl 2 or 10 mM EDTA for 24 hrs after the complex formed was also insufficient to disrupt it (data not shown). We subsequently titrated the cobalt concentration of the reaction (Figure 3C ), finding saturation of complex formation between 10-33 μM, consistent with the nanomolar-to-micromolar affinity of most metal sites (19) . We also tested the kinetics of complex formation by quenching the reaction at various time points. The complex was nearly completely formed within 270 minutes ( Figure  3D ). Quantification of complex formation showed that approximately 10% of TNF was converted to 44 kDa product. The rate of adduct formation was 0.01 pmol/min, corresponding to 1.6x10 7 molecules/second. Despite an expectation of a pH-dependence of the reaction, similar complex formation was seen from pH 5 to 9 ( Figure 3E ). At most a slight increase was seen at pH 6.0 and 6.5 relative to other conditions. We then tested the specificity of the 21H9 scFv by incubating it with the unrelated antigen amphiregulin under the same conditions that produced the 21H9-TNF complex. No Co 2+ ion-dependent adduct formation was seen ( Figure 4A ). Similarly, no reaction was seen with the CD40L antigen under the same conditions (data not shown).
We had previously observed the formation of an extra band on gels stained with the anti-scFv antibody ( Figure 2C , lane 9b; weight ~ 55 kDa), despite the electrophoretic purity of the scFv prep ( Figure 2B ). As many antibody variable regions are self-binding (32), we tested the self-reactivity of 21H9 ( Figure 4B ). In the absence of Co 2+ ion, a single scFv band was seen on a Western blot (lane 1). When Co 2+ was present, a new band was seen at a weight corresponding to an scFv dimer (lane 2). When TNF was added to the reaction (lane 3), the TNF dependent scFv-TNF fusion was observed in addition to the scFv dimer. Thus, the 21H9 scFv appears to dimerize in a cobalt-dependent fashion, perhaps mediated via cross-reactivity of the metal motif with another scFv molecule. Similarly, it was noticed that much unreacted scFv and TNFα remained after incubation, despite metal excess (e.g. Figure 2 , lane 9), suggesting that either the scFv or the target had been rendered incompetent for complex formation. A plausible explanation is that the metal motif has reacted with its own scFv molecule, precluding complex formation with the TNFα target. In this regard, the specific activity of 21H9 to irreversibly bind TNF was found to be 10% by densitometry analysis.
Mapping the crosslink. In order to understand the molecular nature of the 21H9-TNF complex, we excised the 44 kDa complex from a coomassie stained SDS-PAGE gel and subjected the purified band to tryptic digest and mass spectrometry. As controls, an equal amount of pure TNF and 21H9 were also gel purified and analyzed in parallel with the 44 kDa complex. Both MALDI-TOF and HPLC-MS-MS, as well as the surfaced based ionization techniques of MALDI-TOF and nanostructure initiator mass spectrometry (NIMS) (33) were used to analyze the tryptic fragments. NIMS is a new matrix-free ionization technique that yields exceptionally high sensitivity for peptides extracted from gels. While MALDI-TOF and NIMS-TOF produced similar spectra for our analysis, much higher sensitivity was obtained with NIMS, which did not require de-salting. Peptide sequencing by HPLC-MS-MS confirmed that both proteins were indeed present in the excised 44 kDa band.
In NIMS-TOF experiments, we found clear absence of a complex of peaks in the 44kDa complex that was present in TNF. The largest of these was at 909 Da ( Figure 5A) . A doubly charged peak of 455 was unambiguously identified as the peptide IAVSYQTK by HPLC-MS-MS of the TNF digested control.
As expected, HPLC-MS-MS did not identify this peptide in the 44 kDa complex sample. Thus, the 909 Da peak was absent in NIMS and HPLC-MS-MS in the 21H9+TNF complex, but present in the TNF alone control. This region of TNF is a strong candidate for crosslinking to 21H9. Additionally, a second peak at 857 Da was reduced approximately 3 fold in the 44 kDa complex sample, but present in the TNF control. Of note, this peptide was identified by HPLC-MS-MS as VNLLSAIK, which is immediately C-terminal to the IAVSYQTK peptide identified as the 909 peak. Thus, the crosslinked region can be mapped to IAVSYQTK in TNFα, and the crosslink itself may affect trypsin cleavage at K90 to decrease the amount of the adjacent VNLLSAIK peptide. NIMS-TOF analysis also identified a peak at 2525 Da in the complex but not the TNF or 21H9 controls. A 1263 m/z peak was identified by HPLC-MS in the complex, but absent from both TNF and 21H9 controls ( Figure 5B ). Thus, this doubly charged peak of 2525 could represent a crosslinked 21H9-TNFα peptide. 2525 Da is consistent with the Nterminal RGHEAR of 21H9 crosslinked to IAVSYQTKVNLLSAIK of TNFα, plus cobalt and minus three hydrogens ( Figure 5C ). Unambiguous identification by MS-MS could not be accomplished, however, perhaps due to unusual fragmentation patterns induced by cobalt.
Molecular Model. In order to gain insight into the possible molecular mechanism behind complex formation, we employed molecular modeling to visualize 21H9 binding to TNFα (for modeling details, see Materials and Methods). TNF is a homotrimer, shown in orange, blue, and pink subunits in Fig 5C  (middle) .
The region implicated to be crosslinked by mass spectrometry is shown in cyan (IAVSYQTK peptide) and purple (VNLLSAIK peptide) in the schematic (top left) and three dimensional models (middle right and bottom). The molecular model predicts that RA7 binds to large portions of each of two monomers of the TNFα trimer ( Figure 5C ; pink and blue subunits). The 2-residue linker connecting the heavy chain Nterminus to the metal motif is predicted to be sufficient to bring the metal into proximity of one target monomer. The molecular model, built without the mass spectrometry data, features the metal binding site directly opposite the two peptides implicated by MS to be in the crosslink ( Figure 5C ; cyan and purple fragments). Shown in dark blue in stick format are several proximal main-chain amide nitrogen atoms, which, when deprotonated, may potentially become exchange-inert ligands of strong-field metal ions (34) . These include positions V85, Q88, and G129 of TNF. Additionally, carboxylates, carbonyls or other protein groups may also potentially ligand the metal ion, and are shown in sticks.
DISCUSSION
We have engineered a metal-binding motif into an anti-TNFα antibody, and discovered specific HExxH-scFv fusion sequences which form metal-dependent effectively-covalent complexes with their target. The scFv-antigen adduct resists simultaneous boiling, strongly reducing conditions, chemical denaturants, excess metal chelator concentrations, and SDS-PAGE. The adduct contains both TNFα and scFv as indicated by Western blot and peptide sequencing by HPLC-MS-MS, and migrates in SDS-PAGE at the precise molecular weight of an scFv-TNFα fusion protein.
Formation of the scFv-antigen complex was strongly stimulated by Co 2+ ion. There could be at least three potential roles of the metal in the 21H9-TNF reaction. First, the metal could be entirely structural, positioning nearby residues for nucleophilic attack on antigen sidechains or backbone. Second, the metal could catalyze oxidative side chain cross-linking between 21H9 and TNF. Significantly, metal dependent cross-linked side-chains are well known to occur naturally in several amine oxidases and dehydrogenases (35) . These modified side-chains act as cofactors in catalysis, and in some cases have been unambiguously identified by crystallography. Third, cobalt could directly participate in the complex as a metal bridge between antibody and antigen. Transition metal ions containing six outer-shell electrons classically split their ligand fields, yielding effectively exchangeinert complexes (31) . Co(III) complex ions are intriguing because as the ligands participating in coordinate bonding are varied, the d-orbital energy separation changes to alter the spin state of the complex ion. The low spin state of Co(III) complex ions fall classically into the slow ligand exchange regime (31) . Imidazole and main chain amido ligands induce low spin states in Co(III) complex ions, while carboxylate and water ligands induce high spin states in Co(III) complex ions. The spin state change in Co(III) complex ions also dramatically affects the Co 2+/3+ reduction potential, where this value can vary over 1.5 V (31) . We hypothesize that the Co 2+ ions, once bound to the HExxH motif, become oxidized to Co(III) by dioxygen. Oxidation could even be facilitated by endogenous antibody oxidative chemistry (36, 37) . The completed coordination shells from liganding additional protein groups will presumably form at least a bis(histidine) complex. Aqueous solutions of bis(histidine)-cobalt(II) complex ions have a reduction potential around +200 mV versus the normal hydrogen electrode (38) . This reduction potential would allow for dioxygen-mediated oxidation of the preformed Co II complex to the substitutionally-inert Co III complex.
The ligands completing the coordination shell groups, potentially deprotonated main-chain nitrogens, carboxylates, and imidazole nitrogens, may be provided by (i) the antigen target, (ii) another antibody molecule, or (iii) the same antibody chain. We believe that these three possibilities could explain the formation of the scFv-antigen complex (target), the scFv dimer (other antibody molecule), and the large pool of unreacted scFv (own antibody chain).
Tryptic digest and HPLC-MS analysis indicate a new peptide fragment of 2525 Da in the complex that is not present in TNF or 21H9.
This fragment is consistent with a crosslink between the N-terminus of 21H9 and residues 83-98 of TNF with one cobalt atom and minus three hydrogens. This crosslinked region is also consistent with mass spectroscopic data mapping the crosslink to this region of TNF. Thus, current evidence favors an exchange inert cobalt complex as the molecular mechanism behind the crosslink. Similarly, this type of chemistry could be involved in methods that crosslink nucleotide cofactors to their protein active site (39, 40) . We cannot rule out other more complicated chemistry which might produce the 2525 peptide, however. Further study should elucidate the exact molecular species.
The complex is formed upon incubation of antibody and antigen in the presence of Co 2+ ion, and to a far lesser extent with other cations, or with no exogenously added metal. Formation of the complex in the presence of non-exchange-inert metals, as well as no metal, may be a result of contamination with metals such as cobalt or iron, which might produce the observed effect. Close inspection of the 44 kDa band reveals that it is actually a tight doublet ( Figure 4B ).
It is possible that hydrolysis at either terminus of the scFv or target could occur during the cross-linking reaction, producing two closely-related species. It is interesting to note that 21H9 was selected on copper, but its covalent binding activity is far better with cobalt as a cofactor. Metalbinding sites such as the HExxH motif can have a broad metal-binding specificity, particularly when solvent-exposed (41) , explaining the Cu(II) phage panning results. It is possible, however, that similar cobalt dependent binding and reactivity may be more efficiently identified using cobalt resins, which remains to be explored. We have not yet analyzed clones derived from this library that bound cobalt resins. It is reassuring that the reactive scFv does not form complexes with non-target proteins, suggesting that the association kinetics of the metal tag with other protein ligands is sufficiently slow so as to proceed only in the presence of a high local protein concentration, as is the case for the target and the same antibody chain.
Only two of the 35 metal binding scFv's possessed the ability to form the 44 kDa complex. The fact that only a small fraction of the metal motif-containing scFv's react with target suggests that the non-histidine/glutamate sequences contribute to tag reactivity, either by positioning the tag relative to target, controlling tag attack on its own antibody chain, or perhaps by electrostatically modulating the environment of the metal and thus its reactivity. Of note, the two sequences (RGHEARHWA and MRHERAHWW) identified in being able to catalyze formation of the 44 kDa complex had some similarities. Both encoded arginine and alanine in the region between the fixed glutamate and second histidine, albeit in reverse order. Additionally, both encoded tryptophan immediately following the second histidine. The Trp codon (TGG) is amongst the rarest in the library (only one of 32 codons), thus its selection in the same position for both of the clones mediating crosslink formation seems relevant. However, the roles of these amino acids in the reaction mechanism or tertiary structure is unknown. Clear elucidation of the reaction mechanism and mutagenesis studies of these residues should reveal their function and importance.
Additionally, it seems likely that further engineering of the linker sequences and surrounding antibody regions can control self-reactivity, giving rise to an improved reagent.
Reactive antibodies that bind irreversibly to their targets could be useful against highly potent antigens like toxins, or for sequestration of targets outside of their pathologic anatomical location, as in the case of β-amyloid (8) in Alzheimer's or VEGF in metastatic tumors (7) . Steady state diagnostic reagents could also benefit from antibodies with a zero off-rate.
We demonstrate that discovery of irreversibly binding reactive antibodies against unmodified protein targets is a feasible goal. In order to be clinically relevant, however, several further studies will be required. First, the chemistry would need to occur in vivo, in competition with a serum mix that could potentially chelate metal ions. Engineering a high affinity metal binding site, and preloading the antibody with metal could meet this challenge. Second, the specific activity of the antibody will need to be increased through engineering. The current Nterminal extension may be too flexible and lead to alternative folding states, with only one conformation that is active. The use of cocrystal structure information that is available for several antibody-antigen complexes could facilitate a more optimized and rational engineering of reactive metal sites into antibodies. For example, structural information could allow engineering into CDR loops that do not provide significant antigen contact. This would allow a more rigid metal binding domain with superior steric properties that could improve specific reactivity towards antigen while reducing self-reactivity.
Third, the toxicity of a metalloantibody would need to be carefully evaluated in vivo. Cobalt is a trace metal required as a cofactor for several enzymes (42) , and present in vitamin B-12. A half century ago, relatively high doses of cobalt were used in treatment of anemia (43) . However, many metals including cobalt have the propensity to damage DNA through Fenton chemistry mechanisms (44) , and the potential adverse effects of a cobalt metalloantibody are unknown.
Using the model anti-TNFα scFv RA7, we show that it is possible to engineer antibodies that bind to their antigen irreversibly. Such strategies that allow permanent chemical modification of protein antigens could enable discovery of next-generation therapeutics and diagnostics. Utilization of the V H or V L termini to engineer reactive components into antibody combining sites is a general strategy that may be used for other antibodies. Similarly, the ability to screen for metal binding antibodies that grossly modify their target antigen could also be applied to many other antibody-antigen complexes. Other reactive antibodies such as proteolytic and otherwise catalytic anti-protein antibodies could transform the antibody superfamily into a general class of target binding and modifying scaffolds. Figure 1 . Library Construction, Characterization, and Screening. A. HExxH motif from the active site of thermolysin (4TMN). B. The RA72-HExxH phage library binds TNFα. ELISA plates were coated with TNFα and BSA, and incubated with the positive control monoclonal phages RA7 and RA72, the RA72-HExxH library, and the negative control phages D126, vFx9, and M13K07. C. RA72-HExxH phage preferentially elute from a metal column. Equal titers of either RA72 or RA72-HExxH phage were applied to a Ni-chelate resin, washed extensively, and eluted in an imidazole gradient. Eluted phagemids were used to infect E. coli, and titered by colony count on LB-amp plates. The control phage RA72 (left) or 21H9 (right) were incubated with a copper-coated ELISA plate in the absence (black bars) or presence (grey bars) of EDTA (1 mM). Reactions were in triplicate and error bars represent 2.5 SD. B. Purification of scFv. The 21H9 scFv and RA72 control were purified by thiophilic chromatography, cation exchange, and size exclusion chromatography, and resolved by SDS-PAGE (1 μg) and silver stained. A blank lane is shown to illustrate that the faint band above 50 kDa is a staining artifact and not impurity. C. Identification of an effectively covalent TNFα-scFv complex. RA72 (lanes 1-4) or 21H9 (lanes 5-9) were incubated in the absence (lanes 1 and 5) or presence (lanes 2-4 and 6-9) of the indicated metals (100 μM) followed by anti-TNFα western blot (lanes 1-9a) or anti-scFv western blot (lane 9b). The crosslinked region is shown in cyan and adjacent region in purple. These regions are also shown in cyan and purple in a three dimensional model of the TNF trimer, with each subunit shown in pink, orange and blue (middle right). Three dimensional model of 21H9 bound to TNFα (bottom). Green: 21H9 heavy chain; red: HExxH motif; yellow: 21H9 light chain; pink, blue, orange: TNF subunits; dark blue: main-chain amido nitrogens; sticks: potentially liganding side-chains in proximity to the metal.
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